Viewing Study NCT06015035


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-01-01 @ 4:30 PM
Study NCT ID: NCT06015035
Status: COMPLETED
Last Update Posted: 2023-08-29
First Post: 2023-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
Sponsor: Tang-Du Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module